Sterile endophthalmitis rates and particle size analyses of different formulations of triamcinolone acetonide

References

• TanoYChandlerDMachemerRTreatment of intraocular proliferation with intravitreal injection of triamcinolone acetonideAm J Ophthalmol19809068108167446668
   PubMed Web of Science ®Google Scholar
• PenfoldPLGyoryJFHunyorABBillsonFAExudative macular degeneration and intravitreal triamcinolone. A pilot studyAust N Z J Ophthalmol199523429329811980075
   PubMedGoogle Scholar
• TaoYJonasJBIntravitreal triamcinoloneOphthalmologica2011225112020693817
   PubMed Web of Science ®Google Scholar
• WingateRJBeaumontPEIntravitreal triamcinolone and elevated intraocular pressureAust N Z J Ophthalmol199927643143210641903
   PubMedGoogle Scholar
• GilliesMCKuzniarzMCraigJBallMLuoWSimpsonJMIntravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataractOphthalmology2005112113914315629834
   PubMed Web of Science ®Google Scholar
• JonasJBKreissigIDegenringRFEndophthalmitis after intravitreal injection of triamcinolone acetonideArch Ophthalmol2003121111663166414609940
   PubMedGoogle Scholar
• RothDBChiehJSpirnMJGreenSNYarianDLChaudhryNANoninfectious endophthalmitis associated with intravitreal triamcinolone injectionArch Ophthalmol200312191279128212963610
   PubMed Web of Science ®Google Scholar
• RothDBFlynnHWJrDistinguishing between infectious and noninfectious endophthalmitis after intravitreal triamcinolone injectionAm J Ophthalmol2008146334634718724979
   PubMed Web of Science ®Google Scholar
• RothDBRealiniTFeuerWJShort-term complications of intravitreal injection of triamcinolone acetonideRetina2008281667018185140
   PubMed Web of Science ®Google Scholar
• NelsonMLTennantMTSivalingamARegilloCDBelmontJBMartidisAInfectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injectionRetina200323568669114574256
   PubMed Web of Science ®Google Scholar
• SutterFKGilliesMCPseudo-endophthalmitis after intravitreal injection of triamcinoloneBr J Ophthalmol200387897297412881337
   PubMed Web of Science ®Google Scholar
• RothDLeeSSFlynnHWJrMoshfeghiDMInflammatory reactions after intravitreal triamcinolone acetonide: possible mechanisms and therapeutic optionsExpert Rev Ophthalmol201053273276
   Google Scholar
• WestfallACOsbornAKuhlDBenzMSMielerWFHolzERAcute endophthalmitis incidence: intravitreal triamcinoloneArch Ophthalmol200512381075107716087840
   PubMedGoogle Scholar
• WangLCYangCMSterile endophthalmitis following intravitreal injection of triamcinolone acetonideOcul Immunol Inflamm200513429530016159720
   PubMed Web of Science ®Google Scholar
• JonischJLaiJCDeramoVAFlugAJFastenbergDMIncreased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonideBr J Ophthalmol20089281051105418653598
   PubMed Web of Science ®Google Scholar
• StepienKEEatonAMJaffeGJDavisJLRajaJFeuerWIncreased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006Retina200929220721319050670
   PubMed Web of Science ®Google Scholar
• JonasJBKreissigISpandauUHHarderBInfectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonideAm J Ophthalmol2006141357958016490517
   PubMed Web of Science ®Google Scholar
• Kenalog®-40 (triamcinolone acetonide injectable suspension, USP) [package insert]Princeton, NJBristol-Myers Squibb2014
   Google Scholar
• DunbarHHoskinsMDJrLetter on behalf of American Academy of Ophthalmology regarding warning section of the prescribing Information for KENLOG to Freda Lewis-Hall MDBristol-Myers Squibb Company1282006
   Google Scholar
• MaiaMFarahMEBelfortRNEffects of intravitreal triamcinolone acetonide injection with and without preservativeBr J Ophthalmol20079191122112417383993
   PubMed Web of Science ®Google Scholar
• Lorenzo CarreroJPerez FloresIGonzalez BarciaMInfectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonideAm J Ophthalmol20061423529 author reply 529–53016935616
   PubMed Web of Science ®Google Scholar
• OtsukaHKawanoHSonodaSNakamuraMSakamotoTParticle-induced endophthalmitis: possible mechanisms of sterile endophthalmitis after intravitreal triamcinoloneInvest Ophthalmol Vis Sci20135431758176623404123
   PubMed Web of Science ®Google Scholar
• DodwellDGKrimmelDASterile endophthalmitis from Triesence™Platform presentation at: Retina CongressOctober 2, 2009New York, NY, USA
   Google Scholar
• BakriSJEdwardsAOCouchSMNoninfectious endophthalmitis occurring after intravitreal Triesence injectionRetinal Cases Brief Rep20093316318
   Google Scholar
• TakemuraRStenbergPEBaintonDFWerbZRapid redistribution of clathrin onto macrophage plasma membranes in response to Fc receptor-ligand interaction during frustrated phagocytosisJ Cell Biol1986102155692867099
   PubMed Web of Science ®Google Scholar
• FairesJSMcCartyDJJrAcute arthritis in man and dog after intrasynovial injection of sodium urate crystalsLancet19622807258682685
   Google Scholar
• KohnNNHughesREMcCDJrFairesJSThe significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome”. II. Identification of crystalsAnn Intern Med19625673874514457846
   PubMed Web of Science ®Google Scholar
• McCartyDJJrHoganJMInflammatory reaction after intrasynovial injection of microcrystalline adrenocorticosteroid estersArthritis Rheum1964735936714202574
   PubMed Web of Science ®Google Scholar
• SelviEDe StefanoRLorenziniSMarcolongoRArthritis induced by corticosteroid crystalsJ Rheumatol200431362214994418
   PubMed Web of Science ®Google Scholar
• MoshfeghiAANugentAKNomotoHSanisloSRKitchensJWMoshfeghiDMTriamcinolone acetonide preparations: impact of crystal size on in vitro behaviorRetina200929568969819373129
   PubMed Web of Science ®Google Scholar
• ZachariasLCEstrago-FrancoMFRamirezCThe effects of commercially available preservative-free FDA-approved triamcinolone (Triesence(R)) on retinal cells in cultureJ Ocul Pharmacol Ther201127214315021500984
   PubMed Web of Science ®Google Scholar
• ZachariasLCLinTMigonRAssessment of the differences in pharmacokinetics and pharmacodynamics between four distinct formulations of triamcinolone acetonideRetina201333352253122990317
   PubMed Web of Science ®Google Scholar
• BhavsarARIpMSGlassmanARThe risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trialsAm J Ophthalmol2007144345445617765429
   PubMed Web of Science ®Google Scholar
• Triesence® (triamcinolone acetonide injectable suspension) [package insert]Fort Worth, TXAlcon Laboratories2007
   Google Scholar